| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV.
|
J Clin Exp Neuropsychol
|
2004
|
5.18
|
|
2
|
Age-associated predictors of medication adherence in HIV-positive adults: health beliefs, self-efficacy, and neurocognitive status.
|
Health Psychol
|
2007
|
2.62
|
|
3
|
Aging, neurocognition, and medication adherence in HIV infection.
|
Am J Geriatr Psychiatry
|
2009
|
1.64
|
|
4
|
Functional consequences of HIV-associated neuropsychological impairment.
|
Neuropsychol Rev
|
2009
|
1.54
|
|
5
|
Reciprocal prediction of medication adherence and neurocognition in HIV/AIDS.
|
Neurology
|
2010
|
1.50
|
|
6
|
Medication and finance management among HIV-infected adults: the impact of age and cognition.
|
J Clin Exp Neuropsychol
|
2010
|
1.46
|
|
7
|
Adherence to antiretroviral medications in HIV: differences in data collected via self-report and electronic monitoring.
|
Health Psychol
|
2006
|
1.41
|
|
8
|
Longitudinal change in cognitive function and medication adherence in HIV-infected adults.
|
AIDS Behav
|
2011
|
1.35
|
|
9
|
Variations in patterns of highly active antiretroviral therapy (HAART) adherence.
|
AIDS Behav
|
2005
|
1.31
|
|
10
|
Depression, cognition, and self-appraisal of functional abilities in HIV: an examination of subjective appraisal versus objective performance.
|
Clin Neuropsychol
|
2011
|
1.21
|
|
11
|
The effect of recent stimulant use on sustained attention in HIV-infected adults.
|
J Clin Exp Neuropsychol
|
2006
|
1.17
|
|
12
|
Differential predictors of medication adherence in HIV: findings from a sample of African American and Caucasian HIV-positive drug-using adults.
|
AIDS Patient Care STDS
|
2012
|
1.16
|
|
13
|
Reaction time performance in adults with HIV/AIDS.
|
J Clin Exp Neuropsychol
|
2002
|
1.09
|
|
14
|
Risky decision making assessed with the gambling task in adults with HIV.
|
Neuropsychology
|
2006
|
1.09
|
|
15
|
Components of depression in HIV-1 infection: their differential relationship to neurocognitive performance.
|
J Clin Exp Neuropsychol
|
2006
|
1.08
|
|
16
|
Neuropsychological aspects of coinfection with HIV and hepatitis C virus.
|
Clin Infect Dis
|
2005
|
1.07
|
|
17
|
Neurocognitive functioning in HIV-1 infection: effects of cerebrovascular risk factors and age.
|
Clin Neuropsychol
|
2010
|
1.02
|
|
18
|
Multi-dimensional MR spectroscopy: towards a better understanding of hepatic encephalopathy.
|
Metab Brain Dis
|
2011
|
1.00
|
|
19
|
Functional disability in medication management and driving among individuals with HIV: a 1-year follow-up study.
|
J Clin Exp Neuropsychol
|
2012
|
0.95
|
|
20
|
Reaction time variability in HIV-positive individuals.
|
Arch Clin Neuropsychol
|
2010
|
0.94
|
|
21
|
Relationship between psychiatric status and frontal-subcortical systems in HIV-infected individuals.
|
J Int Neuropsychol Soc
|
2007
|
0.93
|
|
22
|
CCL3 genotype and current depression increase risk of HIV-associated dementia.
|
Neurobehav HIV Med
|
2009
|
0.93
|
|
23
|
Elements of attention in HIV-infected adults: evaluation of an existing model.
|
J Clin Exp Neuropsychol
|
2007
|
0.93
|
|
24
|
Basal ganglia structures differentially contribute to verbal fluency: evidence from Human Immunodeficiency Virus (HIV)-infected adults.
|
Neuropsychologia
|
2011
|
0.92
|
|
25
|
Emerging issues in the neuropsychology of HIV infection.
|
Curr HIV/AIDS Rep
|
2008
|
0.88
|
|
26
|
The impact of neurobehavioral features on medication adherence in HIV: evidence from longitudinal models.
|
AIDS Care
|
2013
|
0.88
|
|
27
|
The Item-Specific Deficit Approach to evaluating verbal memory dysfunction: rationale, psychometrics, and application.
|
J Clin Exp Neuropsychol
|
2009
|
0.87
|
|
28
|
Perceptual span deficits in adults with HIV.
|
J Int Neuropsychol Soc
|
2004
|
0.87
|
|
29
|
An exploratory study of long-term neurocognitive outcomes following recovery from opportunistic brain infections in HIV+ adults.
|
J Clin Exp Neuropsychol
|
2008
|
0.87
|
|
30
|
Systems analysis of human brain gene expression: mechanisms for HIV-associated neurocognitive impairment and common pathways with Alzheimer's disease.
|
BMC Med Genomics
|
2013
|
0.86
|
|
31
|
2D MR Spectroscopy Combined with Prior-Knowledge Fitting Is Sensitive to HCV-Associated Cerebral Metabolic Abnormalities.
|
Int J Hepatol
|
2012
|
0.86
|
|
32
|
Cognitive reserve as a protective factor in older HIV-positive patients at risk for cognitive decline.
|
Appl Neuropsychol Adult
|
2012
|
0.85
|
|
33
|
The role of HIV infection, cognition, and depression in risky decision-making.
|
J Neuropsychiatry Clin Neurosci
|
2012
|
0.83
|
|
34
|
Reaction time slowing in adults with HIV: results of a meta-analysis using brinley plots.
|
Brain Cogn
|
2002
|
0.83
|
|
35
|
The generalizability of neurocognitive test/retest data derived from a nonclinical sample for detecting change among two HIV+ cohorts.
|
J Clin Exp Neuropsychol
|
2007
|
0.82
|
|
36
|
Antiretroviral adherence and the nature of HIV-associated verbal memory impairment.
|
J Neuropsychiatry Clin Neurosci
|
2011
|
0.82
|
|
37
|
Subcortical hyperintensities in Alzheimer's disease: associated clinical and metabolic findings.
|
J Neuropsychiatry Clin Neurosci
|
2002
|
0.82
|
|
38
|
Sensation seeking and visual selective attention in adults with HIV/AIDS.
|
AIDS Behav
|
2007
|
0.81
|
|
39
|
Triple trouble: cognitive deficits from hepatitis C, HIV, and methamphetamine.
|
Neurology
|
2005
|
0.81
|
|
40
|
Effects of stereotype threat, perceived discrimination, and examiner race on neuropsychological performance: simple as black and white?
|
J Int Neuropsychol Soc
|
2013
|
0.81
|
|
41
|
Neuropsychological Dysfunction among HIV Infected Drug Abusers.
|
Am J Infect Dis
|
2006
|
0.79
|
|
42
|
Two-dimensional MR spectroscopy of minimal hepatic encephalopathy and neuropsychological correlates in vivo.
|
J Magn Reson Imaging
|
2010
|
0.78
|
|
43
|
The aggregate effects of multiple comorbid risk factors on cognition among HIV-infected individuals.
|
J Clin Exp Neuropsychol
|
2013
|
0.78
|
|
44
|
The role of chemokine C-C motif ligand 2 genotype and cerebrospinal fluid chemokine C-C motif ligand 2 in neurocognition among HIV-infected patients.
|
AIDS
|
2015
|
0.78
|
|
45
|
A deconstruction of gambling task performance among HIV+ individuals: the differential contributions of problem solving and risk taking.
|
J Clin Exp Neuropsychol
|
2013
|
0.76
|
|
46
|
Stability of human immunodeficiency virus type 1 RNA in cerebrospinal fluid determined with the AMPLICOR HIV-1 MONITOR test, version 1.5 (ultrasensitive).
|
J Clin Microbiol
|
2002
|
0.75
|
|
47
|
Neuropsychological exploration of alleged mold neurotoxicity.
|
Arch Clin Neuropsychol
|
2007
|
0.75
|
|
48
|
Longitudinal Intra-Individual Variability in Neuropsychological Performance Relates to White Matter Changes in HIV.
|
Neuropsychology
|
2017
|
0.75
|